Compound details
Schidigerasaponin B1
| Compound ID | CDAMM02816 |
|---|---|
| Common name | Schidigerasaponin B1 | IUPAC name | 16-[5-hydroxy-6-(hydroxymethyl)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl]oxy-7,9,13-trimethyl-5\'-methylidenespiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2\'-oxane]-10-one |
| Molecular formula | C44H68O18 |
| Retention time | 23.91 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 907.434 | Theoretical mz | 907.43 |
| Error | 4.39 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.7801 |
| Inchi key | CIJLYOWWFYEYAN-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C1CC2C(CCC3CC(OC4OC(CO)C(O)C(OC5OCC(O)C(O)C5O)C4OC6OC(CO)C(O)C(O)C6O)CCC32C)C7CC8OC9(OCC(=C)CC9)C(C)C8C17C |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T18639 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | P05230 | FGF1 |
| T18639 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P05230 | FGF1 |
| T40800 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | P05023 | ATP1A1 |
| T40800 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P05023 | ATP1A1 |
| T40800 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P05023 | ATP1A1 |
| T40800 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P05023 | ATP1A1 |
| T40800 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P05023 | ATP1A1 |
| T40800 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P05023 | ATP1A1 |
| T40800 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P05023 | ATP1A1 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |